Statins lower cholesterol by inhibiting HMG-CoA reductase and may play an important role in preventing and treating ischemic stroke beyond cholesterol lowering. Statins impact endothelial dysfunction, thrombogenesis, inflammation, oxidative stress, and angiogenesis, which are processes involved in cerebral ischemic pathogenesis. Pre-stroke statin therapy and acute post-stroke therapy can improve functional outcomes, and discontinuing statins for patients already taking them before stroke may be harmful. Common statin doses used are pravastatin 10-40 mg, atorvastatin 10-80 mg, simvastatin 40 mg, and rosuvastatin 20 mg.